Fidelity Investments’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Fidelity Investments’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$1	–	5827
2023 Q4	$1	Buy	+1	New	+$1	﹤0.01%	5417

Other funds holding DMK

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Fidelity Investments's DMK Position: Q1 2024 in Review

Fidelity Investments sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 1 share — an estimated $1 sold.

Fidelity Investments first reported a position in DMK in Q4 2023 and held it in 1 quarter. The position peaked at $1 in Q4 2023. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

Fidelity Investments reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 1 DMK Pharmaceuticals Corporation Common Stock share in Q1 2024, an estimated $1.
Fidelity Investments first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2023 and held it in 1 quarter.
Fidelity Investments's DMK Pharmaceuticals Corporation Common Stock position peaked at $1 in Q4 2023.
3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.